Ellagic Acid-Loaded sEVs Encapsulated in GelMA Hydrogel Accelerate Diabetic Wound Healing by Activating EGFR on Skin Repair Cells

Abstract

Delayed diabetic wound healing is partially attributed to the functional disorder of skin repair cells caused by high glucose (HG). Small extracellular vehicles (sEVs) loaded with small-molecule drugs represent a highly promising therapeutic strategy. This study aims to evaluate the therapeutic efficacy of ellagic acid-encapsulated small extracellular vesicles (EA-sEVs) in diabetic wound regeneration and to unravel related mechanisms. Cytotoxicity tests of ellagic acid (EA) as liposomal small molecules (LSMs) were performed with the CCK8 assay. EA was incorporated into sEVs obtained from chorionic plate-mesenchymal stem cells (CP-MSCs) to construct EA-engineered sEVs. The protective effects of EA-sEVs on human dermal fibroblasts (HDFs) and human epidermal keratinocytes (HEKs) induced by high glucose (HG) were assessed through the evaluation of their proliferative, migrative and differentiative capabilities. Furthermore, to illustrate the underlying mechanism, the specific biological targets of EA were predicted and confirmed. Finally, EA-sEVs were encapsulated in GelMA hydrogel for investigating the pro-healing effects on diabetic wounds. EA was harmless to cell viability, increasing the possibility and safety of drug development. EA-engineered sEVs were fabricated by loading EA in sEVs. In vitro, EA-sEVs promoted the proliferation, migration, and transdifferentiation of HG-HDFs and the proliferation and migration of HG-HEKs. Mechanism analysis elucidated that epidermal growth factor receptor (EGFR) was the specific biological target of EA. EA interacting with EGFR was responsible for the functional improvement of HG-HDFs and HG-HEKs. In vivo, EA-sEVs encapsulated in GelMA promoted the healing of diabetic wounds by improving re-epithelialisation, collagen formation and the expression of EGFR. Gel-EA-sEVs promoted diabetic wound healing by improving biological functions of HDFs and HEKs. EGFR was first identified as the specific biological target of EA and was responsible for the functional improvement of HG-HDFs and HG-HEKs by Gel-EA-sEVs. Hence, Gel-EA-sEVs can serve as a new promising active dressing for diabetic wound treatment.

Keywords

diabetic wound healing / ellagic acid / fibroblasts / GelMA hydrogel / keratinocytes / small extracellular vesicles

References

[1] D. G. Armstrong, T. W. Tan, A. J. M. Boulton, and S. A. Bus, “Diabetic Foot Ulcers: A Review,” Journal of the American Medical Association 330, no. 1 (2023): 62-75.

[2] R. Wan, J. P. Weissman, K. Grundman, L. Lang, D. J. Grybowski, and R. D. Galiano, “Diabetic Wound Healing: The Impact of Diabetes on Myofibroblast Activity and Its Potential Therapeutic Treatments,” Wound Repair and Regeneration 29, no. 4 (2021): 573-581.

[3] B. Kunkemoeller and T. R. Kyriakides, “Redox Signaling in Diabetic Wound Healing Regulates Extracellular Matrix Deposition,” Antioxidants & Redox Signaling 27, no. 12 (2017): 823-838.

[4] M. Zhang, S. Cui, B. Mao, et al., “Ellagic Acid and Intestinal Microflora Metabolite Urolithin A: A Review on Its Sources, Metabolic Distribution, Health Benefits, and Biotransformation,” Critical Reviews in Food Science and Nutrition 63, no. 24 (2023): 6900-6922.

[5] M. F. do Nascimento, J. C. Cardoso, T. S. Santos, et al., “Development and Characterization of Biointeractive Gelatin Wound Dressing Based on Extract of Punica granatum Linn,” Pharmaceutics 12, no. 12 (2020): 1204, https://doi.org/10.3390/pharmaceutics12121204.

[6] N. Poljšak, S. Kreft, and N. Kočevar Glavač, “Vegetable Butters and Oils in Skin Wound Healing: Scientific Evidence for New Opportunities in Dermatology,” Phytotherapy Research 34, no. 2 (2020): 254-269.

[7] M. Mirhaj, J. Varshosaz, P. M. Nasab, et al., “A Double-Layer Cellulose/Pectin-Soy Protein Isolate-Pomegranate Peel Extract Micro/Nanofiber Dressing for Acceleration of Wound Healing,” International Journal of Biological Macromolecules 255 (2024): 128198.

[8] R. Illescas-Montes, M. Rueda-Fernández, A. González-Acedo, et al., “Effect of Punicalagin and Ellagic Acid on Human Fibroblasts In Vitro: A Preliminary Evaluation of Their Therapeutic Potential,” Nutrients 16, no. 1 (2023): 23, https://doi.org/10.3390/nu16010023.

[9] V. B. Junyaprasert, P. Singhsa, J. Suksiriworapong, and D. Chantasart, “Physicochemical Properties and Skin Permeation of Span 60/Tween 60 Niosomes of Ellagic Acid,” International Journal of Pharmaceutics 423, no. 2 (2012): 303-311.

[10] G. Aichinger, G. Pahlke, L. J. Nagel, W. Berger, and D. Marko, “Bilberry Extract, Its Major Polyphenolic Compounds, and the Soy Isoflavone Genistein Antagonize the Cytostatic Drug Erlotinib in Human Epithelial Cells,” Food & Function 7, no. 8 (2016): 3628-3636.

[11] H. Gehrke, J. Pelka, C. G. Hartinger, et al., “Platinum Nanoparticles and Their Cellular Uptake and DNA Platination at Non-Cytotoxic Concentrations,” Archives of Toxicology 85, no. 7 (2011): 799-812.

[12] H. Blank, R. Schneider, D. Gerthsen, H. Gehrke, K. Jarolim, and D. Marko, “Application of Low-Energy Scanning Transmission Electron Microscopy for the Study of Pt-Nanoparticle Uptake in Human Colon Carcinoma Cells,” Nanotoxicology 8, no. 4 (2014): 433-446.

[13] G. Raposo and W. Stoorvogel, “Extracellular Vesicles: Exosomes, Microvesicles, and Friends,” Journal of Cell Biology 200, no. 4 (2013): 373-383.

[14] M. Karami Fath, J. Azami, A. Masoudi, et al., “Exosome-Based Strategies for Diagnosis and Therapy of Glioma Cancer,” Cancer Cell International 22, no. 1 (2022): 262.

[15] C. Lässer, “Exosomes in Diagnostic and Therapeutic Applications: Biomarker, Vaccine and RNA Interference Delivery Vehicle,” Expert Opinion on Biological Therapy 15, no. 1 (2015): 103-117.

[16] S. Kim, Y. Shin, Y. Choi, et al., “Improved Wound Healing and Skin Regeneration Ability of 3,2'-Dihydroxyflavone-Treated Mesenchymal Stem Cell-Derived Extracellular Vesicles,” International Journal of Molecular Sciences 24, no. 8 (2023): 6964, https://doi.org/10.3390/ijms24086964.

[17] L. J. Born, K. H. Chang, P. Shoureshi, et al., “HOTAIR-Loaded Mesenchymal Stem/Stromal Cell Extracellular Vesicles Enhance Angiogenesis and Wound Healing,” Advanced Healthcare Materials 11, no. 5 (2022): e2002070.

[18] J. Kim, E. H. Kim, H. Lee, J. H. Sung, and O. Y. Bang, “Clinical-Scale Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy for Wound Healing,” International Journal of Molecular Sciences 24, no. 5 (2023): 4273.

[19] Y. Wang, P. Song, L. Wu, et al., “In Situ Photo-Crosslinked Adhesive Hydrogel Loaded With Mesenchymal Stem Cell-Derived Extracellular Vesicles Promotes Diabetic Wound Healing,” Journal of Materials Chemistry B 11, no. 4 (2023): 837-851.

[20] A. Casado-Díaz, J. M. Quesada-Gómez, and G. Dorado, “Extracellular Vesicles Derived From Mesenchymal Stem Cells (MSC) in Regenerative Medicine: Applications in Skin Wound Healing,” Frontiers in Bioengineering and Biotechnology 8 (2020): 146.

[21] Q. Huang, Y. Yang, C. Luo, et al., “An Efficient Protocol to Generate Placental Chorionic Plate-Derived Mesenchymal Stem Cells With Superior Proliferative and Immunomodulatory Properties,” Stem Cell Research & Therapy 10, no. 1 (2019): 301.

[22] Y. Fukuchi, H. Nakajima, D. Sugiyama, I. Hirose, T. Kitamura, and K. Tsuji, “Human Placenta-Derived Cells Have Mesenchymal Stem/Progenitor Cell Potential,” Stem Cells 22, no. 5 (2004): 649-658.

[23] P. S. 't Anker, S. A. Scherjon, C. van der Kleijburg-Keur, et al., “Isolation of Mesenchymal Stem Cells of Fetal or Maternal Origin From Human Placenta,” Stem Cells 22, no. 7 (2004): 1338-1345.

[24] Q. Huang, X. Cheng, C. Luo, et al., “Placental Chorionic Plate-Derived Mesenchymal Stem Cells Ameliorate Severe Acute Pancreatitis by Regulating Macrophage Polarization via Secreting TSG-6,” Stem Cell Research & Therapy 12, no. 1 (2021): 337.

[25] J. Jung, J. H. Choi, Y. Lee, et al., “Human Placenta-Derived Mesenchymal Stem Cells Promote Hepatic Regeneration in CCl4-Injured Rat Liver Model via Increased Autophagic Mechanism,” Stem Cells 31, no. 8 (2013): 1584-1596.

[26] S. Chung, S. Rho, G. Kim, et al., “Human Umbilical Cord Blood Mononuclear Cells and Chorionic Plate-Derived Mesenchymal Stem Cells Promote Axon Survival in a Rat Model of Optic Nerve Crush Injury,” International Journal of Molecular Medicine 37, no. 5 (2016): 1170-1180.

[27] J. Li, Q. Yu, H. Huang, et al., “Human Chorionic Plate-Derived Mesenchymal Stem Cells Transplantation Restores Ovarian Function in a Chemotherapy-Induced Mouse Model of Premature Ovarian Failure,” Stem Cell Research & Therapy 9, no. 1 (2018): 81.

[28] Q. Wei, Y. Wang, K. Ma, et al., “Extracellular Vesicles From Human Umbilical Cord Mesenchymal Stem Cells Facilitate Diabetic Wound Healing Through MiR-17-5p-Mediated Enhancement of Angiogenesis,” Stem Cell Reviews and Reports 18, no. 3 (2022): 1025-1040.

[29] J. Su, Q. Wei, K. Ma, et al., “P-MSC-Derived Extracellular Vesicles Facilitate Diabetic Wound Healing via miR-145-5p/CDKN1A-Mediated Functional Improvements of High Glucose-Induced Senescent Fibroblasts,” Burns & Trauma 11 (2023): tkad010, https://doi.org/10.1093/burnst/tkad010.

[30] J. Rädler, D. Gupta, A. Zickler, and S. E. L. Andaloussi, “Exploiting the Biogenesis of Extracellular Vesicles for Bioengineering and Therapeutic Cargo Loading,” Molecular Therapy 31, no. 5 (2023): 1231-1250.

[31] I. K. Herrmann, M. J. A. Wood, and G. Fuhrmann, “Extracellular Vesicles as a Next-Generation Drug Delivery Platform,” Nature Nanotechnology 16, no. 7 (2021): 748-759.

[32] Q. Li, W. Hu, Q. Huang, et al., “MiR146a-Loaded Engineered Exosomes Released From Silk Fibroin Patch Promote Diabetic Wound Healing by Targeting IRAK1,” Signal Transduction and Targeted Therapy 8, no. 1 (2023): 62.

[33] K. Yue, G. Trujillo-de Santiago, M. M. Alvarez, A. Tamayol, N. Annabi, and A. Khademhosseini, “Synthesis, Properties, and Biomedical Applications of Gelatin Methacryloyl (GelMA) Hydrogels,” Biomaterials 73 (2015): 254-271.

[34] A. G. Kurian, R. K. Singh, K. D. Patel, J. H. Lee, and H. W. Kim, “Multifunctional GelMA Platforms With Nanomaterials for Advanced Tissue Therapeutics,” Bioactive Materials 8 (2022): 267-295.

[35] D. Zhao, Z. Yu, Y. Li, Y. Wang, Q. Li, and D. Han, “GelMA Combined With Sustained Release of HUVECs Derived Exosomes for Promoting Cutaneous Wound Healing and Facilitating Skin Regeneration,” Journal of Molecular Histology 51, no. 3 (2020): 251-263.

[36] K. Man, I. A. Barroso, M. Y. Brunet, et al., “Controlled Release of Epigenetically-Enhanced Extracellular Vesicles From a GelMA/Nanoclay Composite Hydrogel to Promote Bone Repair,” International Journal of Molecular Sciences 23, no. 2 (2022): 832.

[37] Y. Wang, Z. Cao, Q. Wei, et al., “VH298-Loaded Extracellular Vesicles Released From Gelatin Methacryloyl Hydrogel Facilitate Diabetic Wound Healing by HIF-1α-Mediated Enhancement of Angiogenesis,” Acta Biomaterialia 147 (2022): 342-355.

[38] X. Chen, J. Huang, J. Wu, et al., “Human Mesenchymal Stem Cells,” Cell Proliferation 55, no. 4 (2022): e13141.

[39] J. Wang, H. Wu, Y. Peng, et al., “Hypoxia Adipose Stem Cell-Derived Exosomes Promote High-Quality Healing of Diabetic Wound Involves Activation of PI3K/Akt Pathways,” Journal of Nanobiotechnology 19, no. 1 (2021): 202.

[40] L. Wang, S. Liu, K. Li, et al., “General Requirements for the Production of Extracellular Vesicles Derived From Human Stem Cells,” Cell Proliferation 57, no. 3 (2024): e13554.

[41] Z. Chu, Q. Huang, K. Ma, et al., “Novel Neutrophil Extracellular Trap-Related Mechanisms in Diabetic Wounds Inspire a Promising Treatment Strategy With Hypoxia-Challenged Small Extracellular Vesicles,” Bioactive Materials 27 (2023): 257-270.

[42] ASTM, Standard Practice for Assessment of Hemolytic Properties of Materials. ASTM F756-17 (ASTM, 2017).

[43] P. Martin and R. Nunan, “Cellular and Molecular Mechanisms of Repair in Acute and Chronic Wound Healing,” British Journal of Dermatology 173, no. 2 (2015): 370-378.

[44] P. Bainbridge, “Wound Healing and the Role of Fibroblasts,” Journal of Wound Care 22, no. 8 (2013): 407-412.

[45] O. A. Peña and P. Martin, “Cellular and Molecular Mechanisms of Skin Wound Healing,” Nature Reviews. Molecular Cell Biology 25, no. 8 (2024): 599-616.

[46] C. C. Lan, I. H. Liu, A. H. Fang, C. H. Wen, and C. S. Wu, “Hyperglycaemic Conditions Decrease Cultured Keratinocyte Mobility: Implications for Impaired Wound Healing in Patients With Diabetes,” British Journal of Dermatology 159, no. 5 (2008): 1103-1115.

[47] S. Cui, X. Liu, Y. Liu, et al., “Autophagosomes Defeat Ferroptosis by Decreasing Generation and Increasing Discharge of Free Fe(2+) in Skin Repair Cells to Accelerate Diabetic Wound Healing,” Advanced Science 10, no. 25 (2023): e2300414.

[48] J. Y. Bae, J. S. Choi, S. W. Kang, Y. J. Lee, J. Park, and Y. H. Kang, “Dietary Compound Ellagic Acid Alleviates Skin Wrinkle and Inflammation Induced by UV-B Irradiation,” Experimental Dermatology 19, no. 8 (2010): e182-e190.

[49] I. Nyamba, A. Lechanteur, R. Semdé, and B. Evrard, “Physical Formulation Approaches for Improving Aqueous Solubility and Bioavailability of Ellagic Acid: A Review,” European Journal of Pharmaceutics and Biopharmaceutics 159 (2021): 198-210.

[50] L. Gopalakrishnan, L. N. Ramana, S. Sethuraman, and U. M. Krishnan, “Ellagic Acid Encapsulated Chitosan Nanoparticles as Anti-Hemorrhagic Agent,” Carbohydrate Polymers 111 (2014): 215-221.

[51] J. Ahlawat, R. Neupane, E. Deemer, S. T. Sreenivasan, and M. Narayan, “Chitosan-Ellagic Acid Nanohybrid for Mitigating Rotenone-Induced Oxidative Stress,” ACS Applied Materials & Interfaces 12, no. 16 (2020): 18964-18977.

[52] T. Zhang, L. Guo, R. Li, et al., “Ellagic Acid-Cyclodextrin Inclusion Complex-Loaded Thiol-Ene Hydrogel With Antioxidant, Antibacterial, and Anti-Inflammatory Properties for Wound Healing,” ACS Applied Materials & Interfaces 15, no. 4 (2023): 4959-4972.

[53] X. Liu, Q. Wei, Z. Sun, et al., “Small Extracellular Vesicles: Yields, Functionalization and Applications in Diabetic Wound Management,” Interdisciplinary Medicine 1, no. 4 (2023): e20230019.

[54] M. J. Haney, N. L. Klyachko, Y. Zhao, et al., “Exosomes as Drug Delivery Vehicles for Parkinson's Disease Therapy,” Journal of Controlled Release 207 (2015): 18-30.

[55] L. A. Pacheco-Palencia, G. Noratto, L. Hingorani, S. T. Talcott, and S. U. Mertens-Talcott, “Protective Effects of Standardized Pomegranate (Punica granatum L.) Polyphenolic Extract in Ultraviolet-Irradiated Human Skin Fibroblasts,” Journal of Agricultural and Food Chemistry 56, no. 18 (2008): 8434-8441.

[56] A. Tomas, C. E. Futter, and E. R. Eden, “EGF Receptor Trafficking: Consequences for Signaling and Cancer,” Trends in Cell Biology 24, no. 1 (2014): 26-34.

[57] R. J. Bodnar, “Epidermal Growth Factor and Epidermal Growth Factor Receptor: The Yin and Yang in the Treatment of Cutaneous Wounds and Cancer,” Advances in Wound Care 2, no. 1 (2013): 24-29.

[58] S. K. Repertinger, E. Campagnaro, J. Fuhrman, T. El-Abaseri, S. H. Yuspa, and L. A. Hansen, “EGFR Enhances Early Healing After Cutaneous Incisional Wounding,” Journal of Investigative Dermatology 123, no. 5 (2004): 982-989.

[59] Q. Liu, J. Zhang, X. Han, et al., “Huiyang Shengji Decoction Promotes Wound Healing in Diabetic Mice by Activating the EGFR/PI3K/ATK Pathway,” Chinese Medicine 16, no. 1 (2021): 111.

[60] K. Xu and F. S. Yu, “Impaired Epithelial Wound Healing and EGFR Signaling Pathways in the Corneas of Diabetic Rats,” Investigative Ophthalmology & Visual Science 52, no. 6 (2011): 3301-3308.

[61] H. Ma, W. S. Siu, and P. C. Leung, “The Potential of MSC-Based Cell-Free Therapy in Wound Healing-A Thorough Literature Review,” International Journal of Molecular Sciences 24, no. 11 (2023): 9356.

[62] E. Jayathilaka, S. L. Edirisinghe, J. Lee, et al., “Isolation and Characterization of Plasma-Derived Exosomes From Olive Flounder (Paralichthys olivaceus) and Their Wound Healing and Regeneration Activities,” Fish & Shellfish Immunology 128 (2022): 196-205.

[63] S. Meng, Q. Wei, S. Chen, et al., “MiR-141-3p-Functionalized Exosomes Loaded in Dissolvable Microneedle Arrays for Hypertrophic Scar Treatment,” Small 20, no. 8 (2024): e2305374.

[64] Y. Gao, Z. Yuan, X. Yuan, et al., “Bioinspired Porous Microspheres for Sustained Hypoxic Exosomes Release and Vascularized Bone Regeneration,” Bioactive Materials 14 (2022): 377-388.

[65] P. Chen, X. Ning, W. Li, et al., “Fabrication of Tβ4-Exosome-Releasing Artificial Stem Cells for Myocardial Infarction Therapy by Improving Coronary Collateralization,” Bioactive Materials 14 (2022): 416-429.

[66] N. Su, Y. Hao, F. Wang, W. Hou, H. Chen, and Y. Luo, “Mesenchymal Stromal Exosome-Functionalized Scaffolds Induce Innate and Adaptive Immunomodulatory Responses Toward Tissue Repair,” Science Advances 7, no. 20 (2021): eabf7207.

[67] J. C. Chachques, C. Gardin, N. Lila, et al., “Elastomeric Cardiowrap Scaffolds Functionalized With Mesenchymal Stem Cells-Derived Exosomes Induce a Positive Modulation in the Inflammatory and Wound Healing Response of Mesenchymal Stem Cell and Macrophage,” Biomedicine 9, no. 7 (2021): 824.

[68] W. Zhu, Y. Dong, P. Xu, et al., “A Composite Hydrogel Containing Resveratrol-Laden Nanoparticles and Platelet-Derived Extracellular Vesicles Promotes Wound Healing in Diabetic Mice,” Acta Biomaterialia 154 (2022): 212-230.

[69] H. Hu, L. Dong, Z. Bu, et al., “miR-23a-3p-Abundant Small Extracellular Vesicles Released From Gelma/Nanoclay Hydrogel for Cartilage Regeneration,” Journal of Extracellular Vesicles 9, no. 1 (2020): 1778883.

[70] L. Fan, C. Liu, X. Chen, et al., “Exosomes-Loaded Electroconductive Hydrogel Synergistically Promotes Tissue Repair After Spinal Cord Injury via Immunoregulation and Enhancement of Myelinated Axon Growth,” Advanced Science 9, no. 13 (2022): e2105586.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.